Funds & Fund Managers
SLI's Moore calls on Martin Gilbert to demand higher bid for Sky
Fund managers rail at low offer for broadcaster and argue not enough has been done to counter conflicts of interest.
10 blockbuster funds tripped up by Trump
Donald Trump's shock election as US president has shaken up markets and delivered a tricky environment for some of the UK's biggest and most celebrated funds.
Woodford’s worst biotech stock to delist from Nasdaq
Cancer specialist Northwest Biotherapeutics rounds off tough year with switch to new stock exchange, triggering $11 million bond repayment.
Four shares the pros are trading
Lavendon, Blue Prism and Produce Investments among stocks that leading smaller company investors have bought and sold.
Risen from the ashes: 10 top turnaround funds
We highlight 10 of the funds that have bounced back strongly this year, surging from the bottom to the top of their sectors.
10 funds thumped by 2016's market turmoil
With the Brexit vote and Donald Trump's election catching markets off guard this year, we highlight some of the funds struggling in 2016.
Neil Woodford: right-wing Trumpists could topple euro
Fund manager fears eurozone break-up and market mayhem if Donald Trump inspires far-right parties to win Europe's upcoming elections.
Can you profit from the defence spend boom?
As the world becomes a more uncertain place, are investors considering investing in conflict?
Buying global stocks: leave it to the experts or do it yourself?
Is the ability to picks stocks a transnational skill, or should it be left to those who know their market and its nuances?
M&G High Income assets to transfer to JP Morgan
Investors in the £389 million portfolio to be offered roll-over into open-ended alternatives or JP Morgan trust